Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk.

Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk.
复制标题

DOI:
10.1016/j.ccr.2011.09.011
复制
发表时间:
2011-11-15
期刊:
影响因子:
50.3
通讯作者:
Bhatia R
Bhatia R
中科院分区:
医学1区
文献类型:
--
作者:
Li L;Li M;Sun C;Francisco L;Chakraborty S;Sabado M;McDonald T;Gyorffy J;Chang K;Wang S;Fan W;Li J;Zhao LP;Radich J;Forman S;Bhatia S;Bhatia R

文献摘要

参考文献

被引文献

相似文献

治疗相关性骨髓增生或急性髓系白血病(t-MDS/AML)是癌症治疗的主要并发症。我们比较了自体造血细胞移植(aHCT)治疗淋巴瘤后发生t-MDS/AML的患者与未发生t-MDS/AML的对照组CD34+细胞的基因表达。我们在随后发展为t-MDS/AML的患者的ahct前样本中观察到与线粒体功能、代谢和造血调节相关的基因表达改变。向显性t-MDS/AML的进展与细胞周期调节基因的额外改变有关。一个最佳的38个基因PBSC分类器准确地区分了独立患者组中发生或未发生t-MDS/AML的患者。我们的结论是,与t-MDS/AML相关的遗传程序在疾病发病之前就被扰乱了,并准确地识别出有这种并发症风险的患者。
Therapy-related myelodysplasia or acute myeloid leukemia (t-MDS/AML) is a major complication of cancer treatment. We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML. We observed altered gene expression related to mitochondrial function, metabolism, and hematopoietic regulation in pre-aHCT samples from patients who subsequently developed t-MDS/AML. Progression to overt t-MDS/AML was associated with additional alterations in cell-cycle regulatory genes. An optimal 38-gene PBSC classifier accurately distinguished patients who did or did not develop t-MDS/AML in an independent group of patients. We conclude that genetic programs associated with t-MDS/AML are perturbed long before disease onset, and accurately identify patients at risk for this complication.
DOI: 10.1016/j.bbabio.2006.03.013
发表时间: 2006-05-01
影响因子: 4.3
作者:
Grivennikova, Vera G.;Vinogradov, Andrei D.
通讯作者: Vinogradov, Andrei D.
DOI: 10.1038/nature06494
发表时间: 2008-01-17
期刊: NATURE
影响因子: 64.8
作者:
Ebert, Benjamin L.;Pretz, Jennifer;Bosco, Jocelyn;Chang, Cindy Y.;Tamayo, Pablo;Galili, Naomi;Raza, Azra;Root, David E.;Attar, Eyal;Ellis, Steven R.;Golub, Todd R.
通讯作者: Golub, Todd R.
DOI: 10.1200/jco.2006.06.0673
发表时间: 2006-08-01
影响因子: 45.3
作者:
Kalaycio, Matt;Rybicki, Lisa;Bolwell, Brian
通讯作者: Bolwell, Brian
DOI: 10.1016/j.ccr.2007.02.026
发表时间: 2007-05-01
期刊: CANCER CELL
影响因子: 50.3
作者:
Feldser, David M.;Greider, Carol W.
通讯作者: Greider, Carol W.
DOI: 10.1182/blood-2005-08-3431
发表时间: 2006-04-15
期刊: BLOOD
影响因子: 20.3
作者:
Faber, P;Fisch, P;Spyridonidis, A
通讯作者: Spyridonidis, A